Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Improving Viral Protease Inhibitors to Counter Drug Resistance.
TFEB, a master regulator of lysosome biogenesis and autophagy, is a new player in alcoholic liver disease.
Impact of pretransplant mutation status on survival after allogeneic stem cell transplant for acute myeloid leukemia.
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope.
Effect Size and Blinding in Lumateperone Trial.
See All 13 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Effect Size and Blinding in Lumateperone Trial.
Gouse BM, Chang AL, Smith EG. Effect Size and Blinding in Lumateperone Trial. JAMA Psychiatry. 2020 06 01; 77(6):650-651.
View in:
PubMed
subject areas
Antipsychotic Agents
Heterocyclic Compounds, 4 or More Rings
Humans
Schizophrenia
authors with profiles
Eric G Smith MD, MPH